Syros Pharmaceuticals, Inc. Skyrocketed
Tue, Nov 19, 2024 at 07:33 PM
Syros Pharmaceuticals, Inc. (SYRS:NASDAQ) rocketted at $0.28, a gain of 39.2%. On Tue, Nov 19, 2024, SYRS:NASDAQ hit a New 2-Week Intraday Low of $0.19. The stock got featured on our News Catalysts scanner on Thu, Nov 14, 2024 at 01:50 PM in the 'BIOTECH' category. From Tue, Nov 05, 2024, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Nov 11, 2024 at $3.4 with a volume of 1M+.
About Syros Pharmaceuticals, Inc. (SYRS:NASDAQ)
Syros Pharmaceuticals Inc is a biopharmaceutical company pioneering an understanding of the region of the genome controlling the activation and repression of genes.
Top 10 Gainers:
- PainReform Ltd. (PRFX:NASDAQ), 161.68%
- Volato Group Inc. Class A (SOAR:NYSEMKT), 122.7%
- noco-noco Inc. (NCNC:NASDAQ), 67.01%
- Next Technology Holding Inc. (NXTT:NASDAQ), 61.76%
- Interactive Strength Inc. (TRNR:NASDAQ), 55.73%
- Aclaris Therapeutics, Inc. (ACRS:NASDAQ), 46.18%
- Dogwood Therapeutics Inc. (DWTX:NASDAQ), 40.54%
- Syros Pharmaceuticals, Inc. (SYRS:NASDAQ), 39.24%
- S&W Seed Company (SANW:NASDAQ), 34.36%
- Telomir Pharmaceuticals Inc. (TELO:NASDAQ), 34.14%